Pfizer
PFE
2,675 hedge funds and large institutions have $137B invested in Pfizer in 2020 Q4 according to their latest regulatory filings, with 314 funds opening new positions, 669 increasing their positions, 1,691 reducing their positions, and 110 closing their positions.
185% more first-time investments, than exits
New positions opened: 314 | Existing positions closed: 110
18% more call options, than puts
Call options by funds: $2.58B | Put options by funds: $2.19B
7% more funds holding
Funds holding: 2,509 → 2,675 (+166)
3% less capital invested
Capital invested by funds: $140B → $137B (-$3.59B)
5.86% less ownership
Funds ownership: 72.65% → 66.79% (-5.9%)
38% less funds holding in top 10
Funds holding in top 10: 103 → 64 (-39)
60% less repeat investments, than reductions
Existing positions increased: 669 | Existing positions reduced: 1,691
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$185M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$171M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$148M |
| 4 |
Bank of New York Mellon
New York
|
+$141M |
| 5 |
O
OrbiMed
New York
|
+$133M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$1.47B |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.01B |
| 3 |
State Street
Boston,
Massachusetts
|
-$921M |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$694M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$613M |
PFE Hedge Fund Activity: Q4 2020 in Review
2,675 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2020, worth a combined $137B — down 2.6% from $140B a quarter earlier.
Buyers outnumbered sellers: 314 funds opened new PFE positions and 110 closed out — a net gain of 204 holders — while 669 added to existing stakes and 1,691 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $185M. The largest seller was BlackRock, cutting an estimated $1.47B.
- 2,675 institutional investors held Pfizer (PFE) as of Q4 2020, up from 2,509 in Q3 2020.
- Funds reported $137B of Pfizer stock for Q4 2020, down 2.6% quarter-over-quarter.
- 314 funds opened new Pfizer positions in Q4 2020 and 110 closed out, a net change of +204 holders.
- The largest Pfizer buyer in Q4 2020 was Morgan Stanley, an estimated $185M added.
- The largest Pfizer seller in Q4 2020 was BlackRock, an estimated $1.47B sold.
Based on aggregated 13F filings for Q4 2020.